Review Article
Modulation of Adult Mesenchymal Stem Cells Activity by Toll-Like Receptors: Implications on Therapeutic Potential
Table 1
Summary of reported effects on MSC activity by TLR ligands.
| Ligand | Adipogenic | Condrogenic | Osteogenic | Immuno-genicity | Immuno-suppression | Migration | Proliferation | Survival | Source | Species | Ref |
| LPS | | | | | | | | | AD | Human | [23] | | | | | | | | | BM | Human | [43] | | | | | | | | | AD | Human | [44] | | | | | | | | | BM | Human | [45] | | | | | | | | | BM | Mouse | [55] | | | | | | | | | BM | Mouse | [56] | | | | | | | | | BM | Human | [53] | | | | | | | | | BM | Human | [57] |
| PolyIC | | | | | | | | | AD | Human | [23] | | | | | | | | | BM | Human | [43] | | | | | | | | | AD | Human | [44] | | | | | | | | | BM | Human | [53] | | | | | | | | | BM | Human | [57] |
| PGN | | | | | | | | | AD | Human | [23] | | | | | | | | | AD | Human | [44] |
| CpG-ODNs | | | | | | | | | AD | Human | [23] | | | | | | | | | AD | Human | [44] | | | | | | | | | BM | Human | [53] |
| Flagellin | | | | | | | | | AD | Human | [44] | | | | | | | | | BM | Human | [53] |
| Pam3Cys | | | | | | | | | BM | Mouse | [58] |
| LL-37 | | | | | | | | | BM | Human | [53] |
| Fn III1C | | | | | | | | | BM | Human | [53] |
| R-848 | | | | | | | | | BM | Human | [57] |
| LTA | | | | | | | | | BM | Human | [45] |
|
|
(no significant effect), (increase), (inhibition), AD (adipose derived MSCs), BM (Bone marrow MSCs). LPS: Lipopolysaccharide; PolyIC: Polyinosinic:polycytidylic acid; PGN: Peptidoglycan; CpG-ODNs: CpG oligodeoxynucleotides; Fn III1C: Fibronectin fragment III 1C; LTA: Lipoteichoic acid.
|